Neurofibromatosis
Open Access
Abstract
In this Special Issue of Cancer, a series of 10 papers (seven papers, three reviews) on Neurofibromatosis is presented by international leaders in this field of researchKeywords
This publication has 11 references indexed in Scilit:
- Therapy of Sporadic and NF2-Related Vestibular SchwannomaCancers, 2020
- Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway AnalysisCancers, 2020
- An Update on Neurofibromatosis Type 1-Associated GliomasCancers, 2020
- Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 PatientsCancers, 2019
- Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype–Phenotype Correlations in a Large Independent CohortCancers, 2019
- Brain Tumors in NF1 Children: Influence on Neurocognitive and Behavioral OutcomeCancers, 2019
- The Role of Merlin/NF2 Loss in Meningioma BiologyCancers, 2019
- Long-Term Outcomes of Stereotactic Radiosurgery for Vestibular Schwannoma Associated with Neurofibromatosis Type 2 in Comparison to Sporadic SchwannomaCancers, 2019
- Impact of Surgery on Long-Term Results of Hearing in Neurofibromatosis Type-2 Associated Vestibular SchwannomasCancers, 2019
- NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening ProgramCancers, 2019